ABSTRACT
This paper discusses the potential of an international agreement to ensure equitable vaccine distribution, addressing the failures witnessed during the COVID-19 pandemic. COVAX was unable to prevent vaccine monopolization and unequal distribution, which led to significant disparities in vaccination rates and avoidable deaths. Any future agreement on equitable vaccine distribution must address ethical and practical issues to ensure global health equity and access. The proposed agreement should recognize healthcare as a human right and consider vaccines beyond mere commodities, emphasizing the social responsibility of pharmaceutical companies to prioritize affordability, availability, and accessibility, particularly for low-income countries (LICs). Voluntary licensing agreements are suggested as a means to enhance access to essential medicines. The paper also outlines the necessity of international cooperation, with robust compliance mechanisms, to effectively enforce such an agreement and mitigate future health crises.
Subject(s)
COVID-19 Vaccines , COVID-19 , Drug Industry , Health Services Accessibility , Humans , Drug Industry/ethics , COVID-19/prevention & control , COVID-19/epidemiology , International Cooperation , Health Equity , SARS-CoV-2 , Global Health , Developing CountriesABSTRACT
In Mexico, it is not known which institutions use animals for scientific purposes. This work reports, based on data requested from the National Institute of Transparency, Access to Information and Protection of Personal Data (INAI), the types of institutions that use animals for research and how many of these have an ethics committee. Research centres, colleges, hospitals, national institutes, technical colleges, and public universities are the types of institutions that report using animals for experimentation. Only 54% of institutions have ethics committees. Mexican institutions from 2015 to 2021 used a total of 2,112,786 animals. Mammals are the most widely used animal group. The scientific purposes for using animals depend on the type of institution that uses them. In Mexico, it is necessary to update the regulations in order to regulate the use, protection and the care of laboratory animals.
En México se desconoce cuáles son las instituciones que utilizan animales con fines científicos. Se reporta, a partir de datos solicitados al Instituto Nacional de Transparencia, Acceso a la Información y Protección de Datos Personales (INAI), los tipos de instituciones que usan animales y cuántas poseen un comité interno para el cuidado y uso de los animales de laboratorio. Los centros de investigación, colegios, hospitales, institutos nacionales, tecnológicos y universidades públicas son los tipos de instituciones que reportaron usar animales. El 54% de las instituciones poseen comités de ética. Un total de 2,112,786 animales fueron usados por instituciones del 2015 al 2021. Los mamíferos es el grupo animal más utilizado. El uso de los animales se encuentra en función del tipo de institución que los utiliza. En México, es necesario actualizar la normatividad, con el fin de regular el uso, la protección y el cuidado de los animales de laboratorio.
Subject(s)
Animal Experimentation , Mexico , Animals , Animal Experimentation/ethics , Animals, Laboratory , Universities , HumansABSTRACT
This article aims at raising awareness about the intersection of populism and bioethics. It argues that illiberal forms of populism may have negative consequences on the evolution of bioethics as a discipline and on its practical objectives. It identifies at least seven potential negative effects: (1) The rise of populist leaders fosters "epistemological populism," devaluing the expert and scientific perspectives on which bioethics is usually based, potentially steering policies away from evidence-based foundations. (2) The impact of "moral populism" is evident in legislative prioritization of the "morality of common people," often solicited through popular consultations on issues like abortion, drug legalization, or LGBT issues. (3) Populist distrust in autonomous governmental agencies and advisory bodies, including national bioethics commissions, can compromise expert advice, challenging both their authority and decisions. (4) Populists may erode transparency by undermining institutions responsible for it, hindering access to vital information for bioethical research. (5) "Medical populism" creates adversarial dynamics, prompting politicians to make simplistic healthcare policy decisions based on political rather than informed criteria, adversely affecting vulnerable populations. (6) Radical-right populist parties' "welfare chauvinism" may shape healthcare policies, impacting service access and resource allocation, disproportionately affecting vulnerable groups such as migrants, but indirectly affecting the rest of the population. (7) Nationalist sentiments associated with populism may obstruct international collaborations, posing challenges for global bioethics that seeks to address ethical concerns beyond national borders. In summary, these dynamics raise significant bioethical concerns encompassing evidence-based decision-making, transparency, healthcare equity, and global collaboration. How bioethicists may respond to these challenges is discussed.
ABSTRACT
In Mexico, there are no official public and reliably reported data on the total number and species of non-human animals used for scientific purposes. The aim of the current study was to calculate the total numbers of animals used for scientific and educational purposes in Mexico, from January 2015 to October 2021, based on data requested from the National Institute of Transparency, Access to Information and Protection of Personal Data (INAI, in Spanish). In this period, authorised laboratory animal facilities reported the use of 5,437,263 animals for scientific and educational purposes. However, these data should be viewed with caution, since there is no official register of all Mexican institutions that use animals for these purposes. The use of various species of different taxonomic groups was reported, including mammals, birds, reptiles, amphibians, fish and invertebrates. The main scientific purposes of this animal use were: technological development; innovation; laboratory testing; production of biologicals; quality control; diagnostic purposes; basic and applied research; and education. A robust system for the licensing and approval of animal use, as well as a means to ensure compliance with the relevant regulations, are both urgently required. In addition, in order to regulate animal use, monitor animal care and protect their welfare, the creation of a publicly accessible national database that records the number and species of the animals used is imperative.
Subject(s)
Fishes , Reptiles , Animals , Mexico , Amphibians , Mammals , Animals, LaboratoryABSTRACT
Introducción: las enfermedades crónicas van en aumento e implican múltiples consecuencias que, en un determinado momento, con el paso de los años, pueden llegar a un estado terminal de la enfermedad. El objetivo de este estudio fue analizar el discurso de enfermos crónicos sobre la muerte digna, la eutanasia y el suicidio médicamente asistido para visibilizar la necesidad de la regulación de la muerte digna. Materiales y métodos: se llevó a cabo una investigación cualitativa que se inserta dentro del paradigma del construccionismo social, mediante entrevistas a enfermos crónicos de la Ciudad de México, utilizando una guía semiestructurada. Se empleó el análisis del discurso para encontrar convergencias y diferencias en los discursos. Resultados: se entrevistaron siete personas vía telefónica de enero a marzo del 2022. Las principales enfermedades fueron: lupus, cáncer, artritis, diabetes y ovarios poliquísticos. Los discursos convergen hacia una muerte digna sin dolor, sufrimiento, tranquila y en casa. Coinciden sus discursos en legalizar la eutanasia y el suicidio médicamente asistido; sin embargo, hay divergencias en cuanto a solicitarlas. Conclusiones: la experiencia de la enfermedad crónica es un factor importante para aceptar en un futuro la muerte médicamente asistida, sin ser una carga para otros y evitar el dolor y sufrimiento al final de la vida. La religión influye en las decisiones, pero se puede observar una mayor apertura para aceptar la legalización de la muerte médicamente asistida.
Introduction: Chronic diseases are increasing in frequency and entail multiple consequences that can eventually lead to death. The study aim was to analyze the discourse of chronically-ill patients on death with dignity, euthanasia, and medically-assisted suicide to highlight the need for regulation of death with dignity. Materials and Methods: A qualitative study was conducted within the paradigm of social constructionism. A semi-structured guide was used to conduct interviews with chronically-ill patients in Mexico City. Discourse analysis was performed to identify convergences and differences in the discourses. Results: Seven interviews were conducted by telephone from January to March 2022. The main diseases of the interviewees were lupus, cancer, arthritis, diabetes, and polycystic ovaries. The discourses converged toward a preference for dignified death without pain or suffering that was calm, and occurred at home. The discourses included the topics of legalizing euthanasia and medically-assisted suicide, but the patients differed on whether or not these should be requested. Conclusions: The experience of chronic illness was an important factor in accepting medically-assisted death for the patients, who did not wish to be a burden on others and wanted to avoid pain and suffering at the end of their lives. Religion influenced the patients' decisions, but there was openness to accepting legalization of medically-assisted death.
Introdução: a incidência das doenças crônicas vem aumentando, e têm múltiplas consequências que num determinado momento, ao longo dos anos, podem chegar a um estado terminal da doença. O objetivo deste estudo foi analisar o discurso de pessoas com doenças crônicas sobre morte digna, eutanásia e suicídio medicamente assistido para tornar visível a necessidade de regulamentar a morte digna. Materiais e métodos: foi realizada uma pesquisa qualitativa que se insere no paradigma do construcionismo social. Entrevistas com pacientes crônicos na Cidade do México foram realizadas usando um guia semiestruturado. A análise do discurso foi utilizada para encontrar convergências e divergências nos discursos. Resultados: foram realizadas sete entrevistas por telefone no período de janeiro a março de 2022. As principais doenças foram lúpus, câncer, artrite, diabetes e ovários policísticos. Os discursos convergem para uma morte digna sem dor, sofrimento, tranquila e em casa. Seus discursos coincidem na legalização da eutanásia e do suicídio medicamente assistido; entretanto, há divergências quanto à sua solicitação. Conclusões: a experiência da doença crônica é um fator importante para aceitar a morte medicamente assistida no futuro, sem ser um fardo para os outros e evitando a dor e o sofrimento no final da vida. A religião influencia nas decisões, mas observase uma maior abertura para aceitar a legalização da morte medicamente assistida.
Subject(s)
HumansABSTRACT
Several countries have implemented COVID-19 health passes or certificates to promote a safer return to in-person social activities. These passes have been proposed as a way to prove that someone has been vaccinated, has recovered from the disease, or has negative results on a diagnostic test. However, many people have questioned their ethical justification. This article presents some practical and ethical problems to consider in the event of wishing to implement these passes. Among the former, it is questioned how accurate diagnostic tests are as a means of ensuring that a person is not contagious, whether vaccination guarantees immunity, the fact that health passes can be forged, whether they encourage vaccination, and the problem that there is no universally recognized health pass. Among the ethical issues, it is discussed whether health passes promote discrimination and inequality and whether they violate rights to privacy and freedom. It is concluded that health passes have enough ethical justification to be implemented.
Subject(s)
COVID-19 , Humans , Freedom , PrivacyABSTRACT
Bioethics should pay more attention to globalization and some of its consequences than it has done so far. The COVID-19 pandemic would not have been possible without globalization, which has also increased some of its negative consequences. Globalization has intensified wildlife trade in the world. One of the main hypotheses about the origin of this pandemic is that it originated in illegal forms of wildlife trade in China. In the last 30 or 40 years, there have been zoonotic outbreaks at a much frequent pace than before, many of those have been related to wildlife trade. Legal and illegal wildlife trade has grown in the shadow of globalization. Second, globalization has had a huge impact on the redistribution of wealth in the world. Since 1990 income inequality has increased in most high- and in many middle- and low-income countries. A country's level of pre-COVID income inequality is the best predictor of the COVID death rate. These two issues are not unrelated. People living in poverty in LMIC tend to suffer more from infectious diseases and tend to be marginalized from the health sector. Additionally, poverty tends to reproduce the conditions under which zoonotic diseases can more easily spread.
ABSTRACT
A World Health Organization (WHO) Ad Hoc Expert Group on the Next Steps for Covid-19 Vaccine Evaluation recently recommended placebo-controlled trials (PCT) of Covid-19 vaccines. PCTs are ethically acceptable when there is no proven effective and safe treatment for a certain condition. However, there are already some vaccines that have been approved and which have high levels of efficacy and safety. Any new vaccine under development must be tested against the most effective vaccines available. PCTs go against the participants' best interests, by putting them in a position of disadvantage while taking part in a trial, compared with people who are not in the trial and who could get vaccinated. Particularly in high-income countries, many people are getting vaccinated. This means that, following a recent trend in clinical trials, PCTs would have to be conducted in low- and middle-income countries, where there a number of advantages for drug companies, but where fatality rates of Covid-19 are, in many cases, much higher. For this and other reasons having to do with equal rights, participants in control groups should be protected with the most effective vaccines available.
Subject(s)
Biomedical Research/ethics , Biomedical Research/standards , COVID-19 Vaccines/standards , COVID-19/prevention & control , Ethics, Medical , Guidelines as Topic , Placebos/standards , Humans , Pandemics , SARS-CoV-2ABSTRACT
Este artículo tiene el objetivo de analizar los problemas morales del uso de animales no humanos en investigación científica. Para esto se examinan cuatro posturas representativas al interior de este debate: 1) irrestricta, 2) equilibrada, 3) dilemática y 4) abolicionista, las cuales surgen de los compromisos que se toman respecto a ciertas premisas clave con las cuales se está de acuerdo o no. Dichas premisas se refieren a la importancia que le da cada postura a i) la afectación de intereses en animales, ii) la relevancia moral de estos intereses, iii) la justificación por beneficios de la experimentación animal y iv) la importancia del interés humano comparado con el de los otros animales. Cada postura acepta y rechaza un patrón particular de estos puntos, y al hacer explícitos estos compromisos podemos analizar los problemas y contradicciones que posee cada una. Al final se encuentra que las tres primeras posturas contienen incongruencias importantes respecto a la diferencia de tratos que permiten entre humanos y los animales sujetos a experimentación, además de que deben de aceptar en diferente grado el excepcionalismo humano y el especismo para explicarse. Mientras que la postura abolicionista -pese a tener más dificultades prácticas- es más consistente, a la vez que protege a animales humanos y no humanos de ser dañados por estas prácticas (AU)
This paper aims to analyze the moral problems of the use of non-human animals in scientific research. To this end, four representative positions are examined within this debate: 1) unrestricted, 2) balanced, 3) moral dilemma, and 4) abolitionist, which arise from compromises made with respect to certain key premises with which one may or may not agree. These premises refer to the importance given by each position to i) the affectation of animal interests, ii) the moral relevance of these interests, iii) the justification by benefits of animal experimentation, and iv) the importance of human interest compared to that of other animals. Each position accepts and rejects a particular pattern of these points, and making these commitments explicit, we can analyze the problems and contradictions that each position has. In the end we find that the first three positions contain important incongruities regarding the difference of treatment they allow between humans and animals subject to experimentation, besides that they must accept in different degrees human exceptionalism and speciesism to explain themselves. While the abolitionist position-despite having more practical difficulties-is more consistent, it protects human and non-human animals from being harmed by these practices (AU)
Aquest article té l'objectiu d'analitzar els problemes morals de l'ús d'animals no humans en recerca científica. Per a això s'examinen quatre postures representatives a l'interior d'aquest debat: 1) irrestricta, 2) equilibrada, 3) dilemàtica i 4) abolicionista, les quals sorgeixen dels compromisos que es prenen respecte a certes premisses clau amb les quals s'està d'acord o no. Aquestes premisses es refereixen a la importància que li dóna cada postura a i) l'afectació d'interessos en animals, ii) la rellevància moral d'aquests interessos, iii) la justificació per beneficis de l'experimentació animal i iv) la importància de l'interès humà comparat amb el dels altres animals. Cada postura accepta i rebutja un patró particular d'aquests punts, i en fer explícits aquests compromisos podem analitzar els problemes i contradiccions que posseeix cadascuna. Al final es troba que les tres primeres postures contenen incongruències importants respecte a la diferència de tractes que permeten entre humans i els animals subjectes a experimentació, a més de que han d'acceptar en diferent grau l'excepcionalisme humà i l'especisme per a explicar-se. Mentre que la postura abolicionista -malgrat tenir més dificultats pràctiques- és més consistent, alhora que protegeix a animals humans i no humans de ser danyats per aquestes pràctiques (AU)
Subject(s)
Humans , Animals , Animal Experimentation/ethics , Human Experimentation/ethics , Ethics, ResearchABSTRACT
La pandemia de COVID-19 tiene un origen zoonótico: fue transmitida de los animales a los humanos. Lo mismo ha sucedido con otras epidemias recientes (como las causadas por los virus SARS-CoV-1 y H7N9, entre otros). Estas epidemias surgieron en un contexto de explotación animal: el comercio de animales silvestres. Mucha gente ha pedido la prohibición total de la venta de animales silvestres en mercados. Sin embargo, la prohibición puede ser contraproducente y tener peores consecuencias tanto para los animales como para la salud pública. Este artículo argumenta en contra de una prohibición total y a favor de una regulación progresiva que tome en cuenta el bienestar de los animales, pero que tenga como finalidad última la desaparición del comercio de animales silvestres
The COVID-19 pandemic has a zoonotic origin: it was transmitted from animals to humans. The same has happened with other recent epidemics (such as those caused by the virus SARS-CoV-1 and H7N9, among others). These epidemics arose in a context of animal exploitation: the trade in wildlife. Many people have asked for a blanket ban of wildlife trade in wet markets. However, a blanket ban may be counterproductive and have worse consequences both for the animals and for public health. This paper argues against a blanket ban and argues for a progressive regulation that takes into account the welfare of animals, but that has as its final goal the disappearance of trade in wildlife
La pandèmia de la COVID-19 té un origen zoonòtic: es va transmetre dels animals als humans. El mateix ha passat amb altres epidèmies recents (com les causades pels virus SARS-CoV-1 I H7N9, entre d'altres). Aquestes epidèmies van sorgir en un context d'explotació animal: el comerç d'animals silvestres. Molta gent ha demanat la prohibició total de la venda d'animals silvestres en mercats. No obstant això, la prohibició pot ser contraproduent I tenir pitjors conseqüències tant per als animals com per a la salut pública. Aquest article argumenta en contra d'una prohibició total I a favor d'una regulació progressiva que tingui en compte el benestar dels animals, però que tingui com a finalitat última la desaparició del comerç d'animals silvestres
Subject(s)
Humans , Animals , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Pandemics , Zoonoses/epidemiology , Animals, Wild/virology , Commerce/legislation & jurisprudenceABSTRACT
Bioethical approaches to reproductive health have been of utmost importance for the last three decades in Mexico. As Mexican laws regarding abortion, assisted reproduction, and conscientious objection have been modified, a number of social actors with an interest in these areas have realized that they have to educate the different agents who take part in these procedures in a bioethical approach to reproductive health and rights. This strategy was first used in Mexico by the Catholic Church and many Catholic universities. Advocates, scientists, and feminist organizations, as well as some public universities, have also realized that a grounding in bioethics could help health providers to have an ethical frame that supports the provision of abortion services. Bioethics is also a good framework for supporting the legalization of abortion and for more liberal laws regarding assisted reproduction. So, for the last few years, one of the priorities of these two sides, Catholic and secular groups, has been to train healthcare personnel, lawyers, and members of ethics committees and members of Congress in the application of their respective bioethical perspectives.
Subject(s)
Abortion, Induced/ethics , Bioethics/education , Religion , Reproductive Health/education , Female , Humans , Mexico , PregnancyABSTRACT
Since 2007, when Mexico City decriminalized abortion during the first trimester, a debate has been taking place regarding abortion and the right to conscientious objection (CO). Many people argue that, since the provision of abortions (or "legal terminations of pregnancy" as they are called under Mexico City's law) is now a statutory duty of healthcare personnel there can be no place for "conscientious objection." Others claim that, even if such an objection were to be allowed, it should not be seen as a right, since talk about a right to CO may lead to a slippery slope where we may end up recognizing a right to disobey the law. In this paper, I argue that there is a right to CO and that this may be justified through the notions of autonomy and integrity, which a liberal democracy should respect. However, it cannot be an absolute right, and in the case of abortion, it conflicts with women's reproductive rights. Therefore, CO should be carefully regulated so that it does not obstruct the exercise of women's reproductive rights. Regulation should address questions about who is entitled to object, how such objection should take place, and what can legitimately be objected to.